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Truncated cyclin A and cyclin B lacking the N-terminal domain comprising the ‘destruction box’ escape from proteolysis and arrest cells at 
metaphasc. Mutation of a conserved argininc residue of the destruction domain makes cyclin B resistant to proteolysis, Here WC show that mutation 
of the same residue also makes cyclin A resistant to proteolysis. ineither of two situations in which the cyclin degradation pathway is turned on: 
(i! in Xr::tui.“rs extracts of activated eggs where the degradation pathway has been permanently turned on by adding a recombinant undegradablc 
cyclin B in which the arginine residue of the destruction box has been substituted by alanine; (ii) in extracts of metephase If-arrcstcd oocytes after 
Ca’+-dependent i activation of the cytostatic factor (CSF). 
cdc?; Cell cycle; Cyclin degradation 
1. 1NTRODUCTION 2. MATERIALS AND METHODS 
Exit from M phase of the cell cycle requires inactiva- 
tion of cyclin-cdc2 kinases (see [1,2] for reviews). This 
inactivation is brought about by dephosphorylation of
threoninc 161 on the cdc2 subunit 131, which is itself 
dependent on the proteolytic degradation of the cyclin 
subunit [LCG]. Two types of mitotic cyclins, A and Et, are 
detected in most cells and both are able to form active 
comnlcxes with crlr7 rpli rvrl~.r~rn~lat~~ nrnt~nl~cic nf r--‘--I . . ..-- -_-_. Y_.. ‘J_.” ._~...U.“V. Y.Y.“.,.Jd.” V. 
cyclin A and B is thought o be mediated by a ubiquitin- 
dependent process, since polyubiquitin chain formation 
was shown to be required for cyclin destruction [7,8]. 
The N-terminal domain of cyclin B contains a con- 
served stretch of amino acids (RXALXXI). Mutations 
within this domain that inhibit ubiquitin conjugation 
also inhibit degradation [73. The integrity of the arginine 
residue was found to be critical for degradation of cyclin 
B since substitution for cysteine, alonine or serine ren- 
dered it resistant to cell cycle-dependent proteolysis 
[7,9,101. 
The aim of the present work was to test the functional 
equivalence: of the RXALXXI consensus sequence, 
which is also conserved in cyclin A homologs. 
Corresporr&cc mhfress: M. Don.%, CNRS UPR ilnd INSERM U 249, 
l9!9 route de Mendc, BP 5051, 30433 Montpellier Cc&x, France. 
Intcrphusc X~nprrs extracts were prepared according to Felix ct al. 
[I I]. Briefly, unfertilized eggs were collected into MMRQ (50 mM 
NaCI, I mM KCI, 0.5 mM MgCII, 0.05 mM Na-EGTA, 2.5 mM 
Na-HEPES, pH 7.7) and de-jellied wilh 2% cysteine, pH 7.8, washed 
four times and then electrically activated. The activated eggs were 
incubated for 40 min at room temperature and then transferred to cold 
acetate buffer (100 mM potassium acctalc, 7.5 mM mugnesium ucc- 
late. lO,@nl cytochalasin 13, I mM DTT, 5 mM EGTA, pi-i 72). 
CU”..., ..,.^,.>t- Ir,.W_” . . . ,.. -^_^ ..^I? --!-- I^ . . ..-.“!P..-..r!_- A -- In-.!.. Lj*cvxJ tlCS,ILF “UllFl wvd3 ICIIIUYS” ,Jll”‘ LU su111111uLjdLL”LI ,“I 1” nil,, 
at 12,000 xg. The cytoplasmic material was collected from the crushed 
eggs and an ATP-regenerating system, consisting of IO mM creatine 
phosphate. 80 ,ug/ml crcatine kinasc, I rnM ATP (final concentra- 
tions), was added. After spinning for GO min at 100,000 x g, the 
supcrnatant was collcc:cd and kept at -7WC. 
Extracts from unfertilized eggs were prepared in the same way 
except hat clcctric activation was omitted. 
Full-Icngth cyclic B cDNA of the starfish, i2furrhu.srcrirz.s gfwiuiis, 
and the mutant cyciin B-Ala31 (described by Lorca ct al. [9]) were 
cloned in the expression vector, pUEXZZBIB2, downstream of the 
PL lambda promotor. Both cyclins were produced as fusion proteins 
containing 219 residues of the serum albumin-binding domains of 
strcptococcal protein-G at its C-terminus. Expression of the fusion 
proteins was induced by raising the temperature from 30 to 42°C to 
inactivate the thcrnro sensitive ,I repressor encoded in the vector, The 
soluble cyclin B fusion proteins were purified from the bacterial ex- 
lrncts by binding to human serum albumin (HSA)-Sepherose, fol- 
lowed by clution in IO mM HEPES, pH 7.3, containing 0.25 M lithium 
diiodosalicylate, and desalting in 10 mM HEPES pH 7.2, on a Sc- 
phadex G-5 column. 
Starfish cyclin Band furellu cyclin A were translated in vitro in the 
prescncc of [%i]metkionine in rcliculocyte lysates (Promcga) from 
their zspcctive RNAs. These were obtained by in vitro transcription 
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of plasmids pTZcycB [I21 and pGEMScycA [I 31, using T7 and SP6 
RNA polymcrase, respectively. 
Cyclin B-Ala31 and cyclin A-Cys4I mutants were gcneratcd accord- 
ing to an oligonucleotide-directed in vitro mutagenesis system from 
Amcrsham, UK. 
The translation mix containing [“S]mcthioninc-labellcd cyclins was 
added to interphase or metaphasc extracts in a ratio of 2 vols. to 30 
~01s. of extract. Recombinant starfish cyclin B was added to intcr- 
phase xtracts in a ratio of 7 vols. to 30 vols. of extract. After incuba- 
tion at room temperature, 4yl aliquots were transferred into 20~1 of 
SDS gel sample buffer. 
For Western blotting, proteins were transferred from 10% poly- 
acrylamide gels to nitroccllulose (Schlcichcr and Schuell) and reacled 
with rabbit antibodies pecific for cyclin B or cdd, followed by anli- 
rabbit l&is conjugated 10 peroxidase (Amersham). Immunoblors 
were analysed using a chemiluminescent method (Amcrsham E.C.L.) 
according to the manufacturer’s instruction. Cyclin B antiserum and 
affinity-purified antibodies were obtained as described by Lorca et al. 
[9]. cdc2 amibodics (NMPF) were generated against he N-lcrminal 
I2 amino acid peptide of ~34”““‘. 
To measure HI histonc kinasc activilics, the material retained on 
XSA beads was incubated for IO min at room temperature in a reac- 
tion mixture conlaining I mdml HI histoncs (Bochringcr, 
Mannhcim), IO mM MgC&, 200 PM ATP (100 cpm/pmol) in 20 mM 
HEPES, pH 7.4. Reactions were stopped by adding ! vol. of Laemmli 
buffer and the extent of histone phosphorylation was monitored by 
SDS-PAGE, followed by autoradiography. 
3. RESULTS AND DISCUSSION 
3.1. Substinttion of the invuriartt urginine residue in the 
destruction box ofboth cyclin A and Bprevents their 
proteoi)ks in CSF extmcts. 
In vertebrates, unfertilized eggs, ahhough containing 
high cdc2 kinase activity, are prevented from exiting 
metaphase of meiosis II due to the presence of a cyto- 
static factor (CSF). Disappearance of CSF activity 
upon fertilization is caused by a transient increase in 
cytoplasmic free calcium. We have previously reported 
that cyclin proteolysis can be induced in extracts pre- 
pared from Xetlopus eggs arrested at the second meiotic 
metaphase (CSF extracts) by activating a Ca’+lcalmod- 
ulin-dependent process which inactivates CSF [9]. Pa- 
tell cyclin A and starfish cyclin B cDNA were mutated 
to convert the invariant arginine of the predicted de- 
struction box (R41SALGTITN in Putellu [13] or 
R31GALENISN in starfish [12]) respectively, to a cys- 
teine or an alanine to create the derivatives, cyclin A- 
Cys41 and cyclin B-Ala3 1. These mutants and the wild- 
type cyclins, produced and labelled with [%]methionine 
in reticulocyte lysates, were added to CSF extracts. The 
degradation pathway was then turned on by adding 0.6 
mM Ca2+, which results in a transient increase of free 
Ca?+ concentration up to 0.1-l ,uM [9]. As shown in Fig. 
1, neither cyclin A-Cys41 nor cyclin B-Ala31 mutants 
were degraded under such conditions (Fig. I, right). In 
bss ScyclinB A0 
A72 
July 1992 
1-d+ d-liu 
rvild type 
0 10 20 30 0 10 20 50 
Fig. I. An intact destruction box is required ior cyclin A and cyclin 
B degradation after Cn?’ addition in CSF cxtrdcts. [‘5S]methionine- 
Inbelled wild-type Putrilu cyclin A (a, left). ;yclin A-Cys41 mutant (a. 
right), wild-type starfish cyclin B and a truncated form lacking 72 
amino acids from the N-terminus (b, left) or cyclin B-Ala31 mutant 
(b. right) were added to CSF extracts. Samples (4 yl) were taken iit 
the indicated times (min) after the addition of 0.6 mM C&l2 (finrrl 
concentration) and analysed by SDS-PAGE and fluorography. 
contrast, both wild-type cyclin A and B readily undcr- 
went degradation (Fig. 1, left). Besides the full-length 
cyclin B, in vitro translation of starfish cyclin B mRNA 
generates a protein lacking 72 amino acids from the 
N-terminus (472), due to internal initiation at methion- 
ine 73 [14]. In contrast to the wild-type full-length cy- 
clin, this truncated cyclin B did not undergo proteolysis, 
as a result of the truncation of ilie destruction motif, 
R31GALENISN (Fig. lb). 
3.2. Wild type artd mutant cyclins A and B degradation 
in inierphse extracts 
In the next experiments, we used interphase xtracts 
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Fig. 2. Bacterially exprcsscd wild-type cyclin B and cydin B-Ala31 
mutant can each induce histonc HI kinasc activity when added to 
interphase xtracts. (a) Recombinant starfish cyclin B (left) or cyclin 
B-Al331 mutant (right) were added in interphase frog exlrdcts. Sam- 
ples were taken as a function of time and the materials purified on 
HSA beads were analysed either for cyclin B (3) or cdc2 (b) content 
by immunoblotrirrg. or for histone Ml kinrisr activity (c). 
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Fig. 3. Cyclin B-AlaJl-cdc2 kinase switches on degradation of wild- 
type cyclin A ond cyclin B but not thnt or cyclin A-Cys41 and cyclin 
B-Ala31 mutants. Recombinant starfish cyclin B-Ala31 was added to 
interphase Xenoprrs extracts imultaneously with rSS]labelled wild- 
type Purellu cyclin A (a, leh), cyclin A-Cys41 mutant (a, right), wild- 
typ’ starlish cyclin B (b.lcl’t) or cyclin B-Ala31 mutant (b, right). 
Samples were taken at the indicated time after addition of cyclins. 
~!S]labelled cyclin destruction was monitored by SDS-PAGE fol- 
Lowed by autoradiography. 
prepared from Xrtropus eggs 40 min after activation, 
which do not contain any CSF activity or any signifi- 
cant amount of cyclin B-cd& kinase activity. As ex- 
pected, cyclin A and B, both produced in the reticulo- 
cyte system, remained stable in such extracts (data not 
shown). To turn on the cyclin degradation pathway, we 
generated cyclin B-cdc2 kinase activity by adding wild- 
type starfish cyclin B or mutant cyclin B-Ala31, both 
produced in bacteria s C-temzinal fusion proteins con- 
taining the serum albumin-binding region of streptococ- 
cal protein-G (see section 2). These recombinant pro- 
teins formed complexes with cdc2 in extracts and, as a 
consequence, histone Hl kinase activity was efficiently 
produced in interphase xtracts reaching a level similar 
to that found in CSF extracts. This activity could be 
recovered on HSA beads, a protein that avidly binds the 
serum albumin-binding domain of streptococcal pro- 
tein-G (Fig. 2~). Similar amounts of cdc2 and cd& 
associated HI kinase activity were bound to the beads 
in the presence of wild-type or mutant cyclin B, indicat- 
ing that cd& binding to cyclin B and activity are not 
modified by conversion of Arg-31 to Alanine (Fig. 2b 
and c). 
Table I 
Effect of ATP or Mg” depletion on [“S]labelled cyclin A and cyclin 
B degradation i interphase X~~ru~z~s extracts in which recombinant 
starfish cyclin B was added to induce cyclin prouolysis 
Extract reatment Cyclin A 
degradation 
Cyclin B 
degradation 
None 
Hexokinase-glucose 
EDTA (5 mM) 
EGTA (5 mM) 
c -c 
-t 4 
Pure/la cyclin A and cyclin A-Cys41, or starfish cyclin 
B and cyclin BAla31, produced and labelled with 
[?S]methionine in reticulocyte lysate, were then added 
to extracts containing recombinant cyclin B-Ala31-cdc2 
kinase. As shown in Fig. 3 (left), degradation of wild- 
type tracer cyclins A and B readily occurred when HI 
kinase activity increased. In contrast, both mutants, cy- 
clin A-Cys41 and cyclin B-Ala3 1, were resistant to pro- 
teolysis (right). In these xperiments, cdc2 kinase activ- 
ity remained high even after cyclin degradation was 
turned on, because recombinant cyclin B-Ala31 (as well 
as the truncated form arising in the bacterial prepara- 
tion and lacking the destruction box) failed to undergo 
degradation (Fig. 2a, rightj. The somewhat long lag 
phase (30-60 min) observed between the addition of 
recombinant cyclin B-Ala31 and the destruction of the 
tracer cyclin is at least partially accounted for by the 
time required to generate cdc2 kinasc activity. Similar 
results were obtained when recombinant starfish cyclin 
B-Ala31 was substituted for the wild-type protein (not 
shown), although in that case the full-length recombi- 
nant cyclin B underwent proteolysis (Fig. 2a, left). 
Ubiquitin-dependent degradation of cyclins requires 
ATP-Mg” [ 151. As expected, we found that degradation 
of [3sS]methionine-labelled wild-type cyclin A and B was 
completely inhibited when interphase xtracts were ini- 
tially depleted of endogenous ATP by adding hexoki- 
nase (0.2 mg/ml) and ,&b(-t-)-glucose (15 mM). The ad- 
dition of 5 mM EDT& a magnesium chelator, also 
inhibited cyclin destruction, while 5 mM EGTA, a cal- 
cium chelator, had no such effect (Table I). 
Taken together the above experiments show that sta- 
bility of cyclin A murated in the consensus equence 
RXALXXI (the destruction box) is due to its inability 
to be proteolyzed by the ubiquitin pathway, as already 
reported for cyclin B. 
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